BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Company will host an Investor Day on Wednesday, April 6, 2016 at 12:00 p.m. ET in New York, NY. The Company will be joined by several leading cataract, glaucoma, and retina specialists.
